These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 19137016

  • 1. 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways.
    Guo C, Gasparian AV, Zhuang Z, Bosykh DA, Komar AA, Gudkov AV, Gurova KV.
    Oncogene; 2009 Feb 26; 28(8):1151-61. PubMed ID: 19137016
    [Abstract] [Full Text] [Related]

  • 2. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
    Sun HL, Liu YN, Huang YT, Pan SL, Huang DY, Guh JH, Lee FY, Kuo SC, Teng CM.
    Oncogene; 2007 Jun 07; 26(27):3941-51. PubMed ID: 17213816
    [Abstract] [Full Text] [Related]

  • 3. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53.
    Mungamuri SK, Yang X, Thor AD, Somasundaram K.
    Cancer Res; 2006 May 01; 66(9):4715-24. PubMed ID: 16651424
    [Abstract] [Full Text] [Related]

  • 4. The phosphatidylinositol 3-kinase/Akt pathway negatively regulates Nod2-mediated NF-kappaB pathway.
    Zhao L, Lee JY, Hwang DH.
    Biochem Pharmacol; 2008 Apr 01; 75(7):1515-25. PubMed ID: 18243161
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Calbindin-D28K expression induced by glial cell line-derived neurotrophic factor in substantia nigra neurons dependent on PI3K/Akt/NF-kappaB signaling pathway.
    Wang HJ, Cao JP, Yu JK, Zhang LC, Jiang ZJ, Gao DS.
    Eur J Pharmacol; 2008 Oct 24; 595(1-3):7-12. PubMed ID: 18703048
    [Abstract] [Full Text] [Related]

  • 8. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.
    Kang MJ, Ryu BK, Lee MG, Han J, Lee JH, Ha TK, Byun DS, Chae KS, Lee BH, Chun HS, Lee KY, Kim HJ, Chi SG.
    Gastroenterology; 2008 Dec 24; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170
    [Abstract] [Full Text] [Related]

  • 9. Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia.
    Martelli AM, Evangelisti C, Chiarini F, Grimaldi C, Manzoli L, McCubrey JA.
    Expert Opin Investig Drugs; 2009 Sep 24; 18(9):1333-49. PubMed ID: 19678801
    [Abstract] [Full Text] [Related]

  • 10. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
    Feng W, Brown RE, Trung CD, Li W, Wang L, Khoury T, Alrawi S, Yao J, Xia K, Tan D.
    Ann Clin Lab Sci; 2008 Sep 24; 38(3):195-209. PubMed ID: 18715846
    [Abstract] [Full Text] [Related]

  • 11. Targeting mTOR signaling in lung cancer.
    Marinov M, Fischer B, Arcaro A.
    Crit Rev Oncol Hematol; 2007 Aug 24; 63(2):172-82. PubMed ID: 17540577
    [Abstract] [Full Text] [Related]

  • 12. Alpha-chaconine-reduced metastasis involves a PI3K/Akt signaling pathway with downregulation of NF-kappaB in human lung adenocarcinoma A549 cells.
    Shih YW, Chen PS, Wu CH, Jeng YF, Wang CJ.
    J Agric Food Chem; 2007 Dec 26; 55(26):11035-43. PubMed ID: 18044836
    [Abstract] [Full Text] [Related]

  • 13. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
    Serra V, Markman B, Scaltriti M, Eichhorn PJ, Valero V, Guzman M, Botero ML, Llonch E, Atzori F, Di Cosimo S, Maira M, Garcia-Echeverria C, Parra JL, Arribas J, Baselga J.
    Cancer Res; 2008 Oct 01; 68(19):8022-30. PubMed ID: 18829560
    [Abstract] [Full Text] [Related]

  • 14. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.
    He HN, Wang X, Zheng XL, Sun H, Shi XW, Zhong YJ, Huang B, Yang L, Li JK, Liao LC, Zhang L, Hu LN, Lin Y.
    Cancer Lett; 2010 Sep 01; 295(1):38-43. PubMed ID: 20207071
    [Abstract] [Full Text] [Related]

  • 15. Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch.
    Dogra C, Changotra H, Wergedal JE, Kumar A.
    J Cell Physiol; 2006 Sep 01; 208(3):575-85. PubMed ID: 16741926
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B.
    Agouni A, Sourbier C, Danilin S, Rothhut S, Lindner V, Jacqmin D, Helwig JJ, Lang H, Massfelder T.
    Carcinogenesis; 2007 Sep 01; 28(9):1893-901. PubMed ID: 17468516
    [Abstract] [Full Text] [Related]

  • 18. From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy.
    Georgakis GV, Younes A.
    Expert Rev Anticancer Ther; 2006 Jan 01; 6(1):131-40. PubMed ID: 16375650
    [Abstract] [Full Text] [Related]

  • 19. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C, Zazzeroni F, Papa S, Bubici C, Franzoso G.
    Methods Mol Biol; 2009 Jan 01; 512():169-207. PubMed ID: 19347278
    [Abstract] [Full Text] [Related]

  • 20. Mycobacterium bovis Bacillus Calmette-Guérin (BCG)-induced activation of PI3K/Akt and NF-kB signaling pathways regulates expression of CXCL10 in epithelial cells.
    Méndez-Samperio P, Pérez A, Rivera L.
    Cell Immunol; 2009 Jan 01; 256(1-2):12-8. PubMed ID: 19181310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.